Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

ALRN-6924 may prevent hair loss caused by chemotherapy.

These medications for BPH have known risks and may have new side effects.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Blocking interferon-gamma might help treat various autoimmune diseases.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Baricitinib is effective and safe for treating alopecia areata.

A(1-7) treatment reduces symptoms of lupus in mice.